Galmed Pharmaceuticals Ltd.
EOCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595353
No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $85.9K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Galmed Pharmaceuticals Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 26 | 24 | −2 |
| Shares | 4.23M | 3.88M | −355.2K (−8.4%) |
| Value | $11.8M | $7.05M | −$4.75M (−40.2%) |
New holders (5)
Institutions that held Galmed Pharmaceuticals Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 35,973 | $65.0K | 0.01% |
| Lindbrook Capital, LLC | 11,500 | $21.0K | 0.00% |
| Group One Trading, L.P. | 7,138 | $13.0K | 0.00% |
| TD Waterhouse Canada Inc. | 1,000 | $2.58K | 0.00% |
| PYA Waltman Capital, LLC | 1,000 | $2.00K | 0.00% |
Sold out (7)
Institutions that held Galmed Pharmaceuticals Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Rockefeller Capital Management L.P. | 35,419 | $98.0K |
| Citadel Advisors LLC | 28,114 | $78.0K |
| Squarepoint Ops LLC | 25,404 | $71.0K |
| Toroso Investments, LLC | 24,657 | $69.0K |
| Tower Research Capital LLC (TRC) | 1,815 | $5.00K |
| Royal Bank of Canada | 1,000 | $3.00K |
| Steward Partners Investment Advisory, LLC | 500 | $1.00K |